PLAU and cancer: A possible interpretation of these findings could be that after absorption through the animal peritoneal vascular system, an effective dose of 213Bi-PAI2 can prevent the dissemination of the cancer and completely target and kill metastatic cancer cells or micrometastases that express uPA, leading to their complete regression.